"Evaluation of a Nuclear Receptor-Binding SET Domain 2 (NSD2) Inhibitor" by Katie Impelman, Lea Stitzlein et al.

Menu

Skip to main content

Evaluation of a Nuclear Receptor-Binding SET Domain 2 (NSD2) Inhibitor for the Treatment of Leukemia & Brain Tumors

Evaluation of a Nuclear Receptor-Binding SET Domain 2 (NSD2) Inhibitor for the Treatment of Leukemia & Brain Tumors

Katie Impelman, The University of Texas MD Anderson Cancer Center
Lea Stitzlein, The University of Texas MD Anderson Cancer Center
Virginia Giuliani, The University of Texas MD Anderson Cancer Center
Joya Chandra, The University of Texas MD Anderson Cancer Center

Description

This paper has been withdrawn.